A nurse practitioner gives her advice for managing adverse events during treatment with talquetamab for multiple myeloma.

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, ...

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard reveals how multiple myeloma, a form of blood cancer, begins and ...

I share how I survived multiple myeloma, painful spine fractures and years of recovery to reclaim my independence and ...

Ciara Freeman, MD, PhD, discusses the challenges of incorporating anito-cel into the treatment protocol for patients with multiple myeloma.

The role of IgG4 in the pathogenesis of IgG4-related disease remains unclear, particularly regarding whether IgG4 actively induces histopathological changes or if its elevation is merely a byproduct ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

New research from COMy 2025 reveals a high rate of infections among people with relapsed or refractory multiple myeloma ...

Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

During a live event, Naresh Bumma, MD, discussed CRS, oral and skin toxicities, and low discontinuation rates with ...

Multiple myeloma is a disease that most people haven’t heard of until it impacts their lives directly. This blood cancer can sound daunting but understanding it is the first step towards ...